Cortechs.ai software

For the assessment of traumatic brain injury and other neurodegenerative conditions. The NeuroQuant TBA Report provides physicians a quick reference and in-depth look on regional and global brain structure volumes, which could occur as a result of a brain injury or neurodegenerative disease, by providing volume measurements of 47 brain structures for both the right and left hemisphere, total structure – all sorted by lobe and region.

For the assessment of brain volumes for multiple sclerosis and age-associated neurodegenerative conditions. The NeuroQuant Multi-Structure Atrophy Report presents volumetric information for whole brain, superior lateral ventricles, thalamus, cortical gray matter, cerebral white matter, cerebral white matter hypointensities, 3d ventricle, hippocampus, and inferior lateral ventricles. The MSA report supports physicians in their assessment of patients aged 3-100.

NeuroQuant TBI Triage Brain Atrophy Report - For the assessment of traumatic brain injury and other neurodegenerative conditions. The NeuroQuant TBI Report provides physicians a quick reference and in-depth look on regional and global brain structure volumes, which could occur as a result of a brain injury or neurodegenerative disease, by providing volume measurements of 47 brain structures for both the right and left hemisphere, total structure – all sorted by lobe and region.

For the assessment of multiple sclerosis and other neurodegenerative conditions. Automatically label, visualize and obtain the volumetric quantification of segmentable brain structures and lesions from MRI brain studies—within minutes. NeuroQuant MS combines T2 FLAIR with 3D T1 MR images to enhance your ability to identify and monitor the number and progression of brain lesions. Accurately visualizing lesions and lesion volume change enables you to deliver an efficient, objective assessment of disease activity, so you can determine the best course of treatment more quickly.

OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS scoring.